Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-009449
Filing Date
2020-04-17
Accepted
2020-04-17 16:17:00
Documents
2
Period of Report
2020-04-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1633
2 POWER OF ATTORNEY ea120744-3ex24_hoththerap.htm EX-24 5876
  Complete submission text file 0001213900-20-009449.txt   8829
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Issuer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address
Linsley Wayne (Reporting) CIK: 0001809972 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38803 | Film No.: 20799916